Aclaris Therapeutics

ACRS
Delayed Nasdaq - 05/17 10:00:00 pm
5.64USD
-2.08%
Upcoming events on ACLARIS THERAPEUTICS INC
06/06/19 Annual General Meeting
08/05/19 Interim 2019 Earnings Release (Projected)
11/04/19 Q3 2019 Earnings Release (Projected)
03/12/20 FY 2019 Earnings Release (Projected)
Past events on ACLARIS THERAPEUTICS INC
05/08/19 | 05:00pmQ1 2019 Earnings Call
05/08/19Q1 2019 Earnings Release
04/04/19William Blair Late-Stage Therapeutics Conference
03/18/19FY 2018 Earnings Release
Upcoming sector events for ACLARIS THERAPEUTICS INC
05/20/19 | 03:00pm INCYTE CORPORATION : UBS Global Healthcare Conference
05/20/19 GENMAB A/S : UBS Global Healthcare Conference
05/20/19 | 02:00pm SEATTLE GENETICS, INC. : Annual General Meeting
05/20/19 | 10:00am REGENERON PHARMACEUTICALS INC : UBS Global Healthcare Conference
Past sector events for ACLARIS THERAPEUTICS INC
05/17/19 | 11:00amREGENERON PHARMACEUTICALS INC : Barclays Biopharmaceuticals CEO/CFO Conference
05/17/19 | 09:30amNEKTAR THERAPEUTICS : Drug Discovery Nexus Conference
05/17/19 | 03:00amHANGZHOU TIGERMED CONSULTING CO LTD : Annual General Meeting
05/16/19 | 12:20pmALNYLAM PHARMACEUTICALS, INC. : Bank of America Merrill Lynch Health Care Conference
Annual results
Annual results20182019 (e)
Sales
Million $
Released
Forecast
Spread
10,1
9,87
2,2%

22,8
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-134
-123
-8,9%

-112
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-135
-141
4,0%

-124
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-133
-139
4,8%

-115
Net income
Million $
Released
Forecast
Spread
-133
-139
4,8%

-115
EPS
 $
Released
Forecast
Spread
-4,03
-4,17
3,3%

-2,79
Announcement Date03/18/2019
Quarterly / Semiannualy publications
Quarterly resultsQ1
2019
Q2
2019 (e)
Sales
Million $
Released
Forecast
Spread
5,04
4,81
4,7%

5,55
Operating income (EBITDA)
Million $
Released
Forecast
Spread

-30,9

-29,1
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-37,3
-31,8
-18%

-31,4
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-37,6
-31,6
-19%

-29,3
Net income
Million $
Released
Forecast
Spread
-37,6
-31,6
-19%

-29,3
EPS
 $
Released
Forecast
Spread
-0,91
-0,79
-15%

-0,73
Announcement Date05/08/2019
Operating profit - Rate of surprise
EPS - Rate of surprise